Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Return Of The Me-Too? Big Pharma's 2016 Approval Prospects Stick To Familiar Categories

Executive Summary

Few pending novel agents from big pharma are first-in-class, as firms look to build their portfolios in crowded areas that still have big sales potential – especially in immunology and immuno-oncology.



Related Companies